0 followers
With a new and rapid technology to measure biomarkers, carefully benchmarked against current gold standards, we seek to drive a disruptive shift in capability, access, and precision of biomarker data for screening and diagnostics.
We aim to make Fragment synonymous with rapid biosensing.
Chamindie Punyadeera
This company has no teams yet